Ethyl (2E)-4-Oxo-2-butenoate For Osteoporosis Products

Ethyl (2E)-4-Oxo-2-butenoate For Osteoporosis Products

Ethyl trans-4-oxo-2-butenoate is an intermediate of Minodronic Acid. Indications of Minodronic acid hydrate: Osteoporosis (Minodronate intermediate, the product is used in the treatment of osteoporosis)
Chat Now

Product Details


Chemical Name

Ethyl (2E)-4-Oxo-2-butenoate


(E)-Ethyl 4-oxobut-2-enoate
(2E)-4-Oxo-2-butenoic Acid Ethyl Ester; 
Fumaraldehydic Acid Ethyl Ester; 
(2E)-4-Oxobut-2-enoic Acid Ethyl Ester; 
(E)-Ethyl 4-Oxo-2-butenoate; 
Ethyl (2E)-4-Oxobut-2-enoate; 
Ethyl Fumaraldehydate; 
Ethyl trans-4-Oxo-2-butenoate;



Related product

Minodronic Acid


Minodronic acid is used to treat   hypercalcemia caused by osteoporosis and malignant tumors. Its inhibitory   activity on bone resorption is 2 of disodium incadronate, sodium alendronate   and disodium pamidronate. Times, 10 times and 100 times. It has significant   benefits in the incidence of spinal fractures and a significant reduction in   gastrointestinal side effects. It has now been identified as an effective new   anti-osteoporotic drug to prevent fractures. And Ethyl   Trans-4-oxo-2-butenoate CAS 2960-66-9 is an important intermediate of   Minodronic Acid.


Osteoporosis is a systemic system in   which bone microstructure is damaged, bone mineral components and bone matrix   are constantly reduced, bone is thinner, bone trabeculae are reduced, bone   fragility is increased, and the risk of fracture is increased Disorders of   bone metabolism. Generally divided into two categories, namely primary   osteoporosis and secondary osteoporosis.


You Might Also Like